InvestorsHub Logo
icon url

sage4

01/08/24 12:20 PM

#446815 RE: bas2020 #446814

‘FDA increasingly approves drugs without conclusive proof they work.’

Hope that’s the case for Rett girls and of course for us investors.
High volume today.
Thanks.
icon url

sage4

01/08/24 1:26 PM

#446824 RE: bas2020 #446814

Bas, so where does Sarepta stand now?
Did they fail and are still pursuing for a FDA approval?
SP dropped 40% to $63 on a bad news in Oct 2023; today at $98: a half recovered from the SP prior to the news.
I don't get its CEO said: “met the standard" to show "evidence of effectiveness.”
Maybe we can say that if Blarcamesine beats Acadia's drug for Rett?